Prevalence of plasma autoantibody against cancer testis antigen NY-ESO-1 in HTLV-1 infected individuals with different clinical status

BACKGROUND: Detection of specific immune responses against cancer/testis antigen NY-ESO-1 was recently reported in patients with adult T-cell leukemia/lymphoma (ATL) and human T-cell leukemia virus type 1 (HTLV-1)-infected asymptomatic carriers (ACs). However, the relationship of the responses with...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiohama, Yasuo, Naito, Tadasuke, Matsuzaki, Toshio, Tanaka, Reiko, Tomoyose, Takeaki, Takashima, Hiroshi, Fukushima, Takuya, Tanaka, Yuetsu, Saito, Mineki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512893/
https://www.ncbi.nlm.nih.gov/pubmed/28716148
http://dx.doi.org/10.1186/s12985-017-0802-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512893/
https://www.ncbi.nlm.nih.gov/pubmed/28716148
http://dx.doi.org/10.1186/s12985-017-0802-9

Ejemplares similares